12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      IL-33-activated murine mast cells control the dichotomy between RORγt+ and Helios+ Tregs via the MK2/3-mediated IL-6 production in vitro.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In mast cells, IL-33 typically induces the activation of NF-κB, which results in the production of cytokines such as IL-6 and IL-2. Here, we demonstrate that the IL-33-induced IL-6 production in murine mast cells and the formation of RORγt+ Tregs essentially depends on the MAPKAPs, MK2, and MK3 (MK2/3) downstream of MyD88. In contrast to this, the IL-33-induced and MyD88-dependent IL-2 production in mast cells contributes to the maintenance of Helios+ Tregs . Thereby, the IL-33-induced IL-2 response and, thus, the maintenance of Helios+ Tregs are limited by an IL-6-mediated autocrine negative feedback stimulation acting on mast cells. Collectively, we present MK2/3 in IL-33-activated mast cells as a signaling node, which controls the dichotomy between RORγt+ Treg and Helios+ Treg in vitro.

          Related collections

          Author and article information

          Journal
          Eur J Immunol
          European journal of immunology
          Wiley
          1521-4141
          0014-2980
          December 2019
          : 49
          : 12
          Affiliations
          [1 ] Institut für Immunologie, Universitätsklinikum Jena, Jena, Germany.
          [2 ] Institut für Zellbiochemie, Medizinische Hochschule Hannover, Hannover, Germany.
          Article
          10.1002/eji.201948154
          31334837
          270f1d83-1377-4fa9-97fb-b0f360c6620c
          © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
          History

          IL-33,IL-6,MK2/3,Mast cells,Tregs
          IL-33, IL-6, MK2/3, Mast cells, Tregs

          Comments

          Comment on this article